Mosapride Citrate/Rebamipide
枸橼酸莫沙必利/雷巴米特
Report date: 2024/03/26 16:18:28
Base Information
Drug NameMosapride Citrate/Rebamipide
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Mosapride CitrateRebamipide
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIldong Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesIldong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A